Georgi O.
- Country
- Bulgaria
- Department
- First ward of the Clinic of Psychiatry
Research Overview
- A Phase 2a Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of GXV813 in Hospitalized Adults with Schizophrenia
- Efficacy and Safety Evaluation of ACP-204 Tartrate in Adults with Alzheimer's Disease Psychosis: A Double-Blind, Placebo-Controlled Study
- Evaluation of Long-Term Safety and Tolerability of ACP-204 Tartrate in Adults with Alzheimer's Disease Psychosis: A 52-Week Open-Label Extension Study
Data & Insights
Has run more than one trial at 48 of 70 partner sites.
Specializations
Neuropsychiatric Disorders
This investigator specializes in the treatment of severe psychiatric conditions, with particular emphasis on schizophrenia and its therapeutic management through innovative approaches.
- Novel therapeutic interventions for schizophrenia
- Long-term treatment outcomes
- Oral medication efficacy
Research focuses on evaluating new therapeutic compounds for managing symptoms in adult patients.
Mood Disorders
The investigator conducts research in significant mood disorders, including Major Depressive Disorder and Bipolar I Disorder, with emphasis on treatment-resistant cases.
- Adjunctive treatment approaches
- Acute manic episode management
- Antidepressant therapy optimization
Special attention is given to developing therapeutic solutions for patients with inadequate response to conventional treatments.
Neurodegenerative Conditions
Research extends to the complex intersection of neurodegenerative disease and psychiatric symptoms, particularly Alzheimer's Disease Psychosis.
- Long-term safety assessments
- Psychosis management in Alzheimer's
- Treatment tolerability studies
Focus includes evaluating therapeutic interventions for managing psychotic symptoms in neurodegenerative conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.